Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ...
Scott Hutton, CEO, highlights the impact of the CHEST conference on Nodify utilization metrics, indicating a shift in strategy and increased adoption. Plans for achieving positive adjusted EBITDA in the second half of next year include growing test volumes, revenue, and managing expenses efficiently.